Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2030944 | 1.00 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL2030947 | 1.00 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL1114498 | 0.87 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL1978800 | 0.87 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL657946 | 0.85 | ALOX5 (0.44) | ALOX5 | |
| SCHEMBL657947 | 0.85 | ALOX5 (0.44) | ALOX5 | |
| SCHEMBL1114571 | 0.83 | ALOX5 (0.38) | ALOX5 | |
| SCHEMBL1246039 | 0.81 | ALOX5 (0.39) | ALOX5 | |
| SCHEMBL9457010 | 0.81 | MEN1 (0.32) | — | |
| SCHEMBL9457333 | 0.76 | FFAR4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889894-B2 | Compounds for use in therapy | BANGOR UNIVERSITY (GB) | 2014-11-18 | — | — | US | disclosed |
| EP-2620158-A1 | Adjuvants for use in vaccination | Bangor University (GB) | 2013-07-31 | — | — | EP | disclosed |
| US-20110150981-A1 | Compounds for Use in Therapy | BANGOR UNIVERSITY (GB) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150981-A1 | Compounds for Use in Therapy | CD4, MSR1, TST | ALOX5 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.